Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 341 shares at $76.39 ($26K) on 2020-07-31, disclosed to the SEC on 2020-08-03.
Open-market sale of $26k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |